American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$389M |
| 2 |
Meta Platforms (Facebook)
META
|
+$296M |
| 3 |
Salesforce
CRM
|
+$207M |
| 4 |
Howmet Aerospace
HWM
|
+$122M |
| 5 |
Reinsurance Group of America
RGA
|
+$121M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$349M |
| 2 |
Visa
V
|
+$249M |
| 3 |
IQVIA
IQV
|
+$234M |
| 4 |
T-Mobile US
TMUS
|
+$226M |
| 5 |
NXP Semiconductors
NXPI
|
+$212M |
Sector Composition
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
GitLab
GTLB
$8.07B
| $209K | ﹤0.01% |
+4,094
| New | +$209K |
|
2502
Bally's
BALY
$489M
| $207K | ﹤0.01% |
+13,312
| New | +$207K |
|
2503
Pulmonx
LUNG
$67.2M
| $204K | ﹤0.01% |
+15,588
| New | +$204K |
|
2504
Clearway Energy Class A
CWEN.A
$3.19B
| $204K | ﹤0.01% |
7,554
-96
| -1% | -$2.59K |
|
2505
Evolv Technologies
EVLV
$1.37B
| $204K | ﹤0.01% |
+33,991
| New | +$204K |
|
2506
Aviat Networks
AVNW
$290M
| $203K | ﹤0.01% |
+6,092
| New | +$203K |
|
2507
AdaptHealth
AHCO
$1.24B
| $203K | ﹤0.01% |
+16,676
| New | +$203K |
|
2508
Tarsus Pharmaceuticals
TARS
$2.31B
| $203K | ﹤0.01% |
+11,220
| New | +$203K |
|
2509
Alta Equipment Group
ALTG
$247M
| $203K | ﹤0.01% |
11,687
-738
| -6% | -$12.8K |
|
|
AGTI
2510
DELISTED
Agiliti, Inc.
AGTI
| $202K | ﹤0.01% |
+12,271
| New | +$202K |
|
2511
QuantumScape
QS
$4.71B
| $202K | ﹤0.01% |
25,297
+3,142
| +14% | +$25.1K |
|
2512
ASGN Inc
ASGN
$2.25B
| $201K | ﹤0.01% |
2,660
-4,620
| -63% | -$349K |
|
2513
Mitek Systems
MITK
$453M
| $198K | ﹤0.01% |
+18,300
| New | +$198K |
|
2514
CleanSpark
CLSK
$2.82B
| $197K | ﹤0.01% |
46,034
-114,164
| -71% | -$490K |
|
2515
Bausch Health
BHC
$2.67B
| $197K | ﹤0.01% |
24,636
| – | – |
|
|
BIG
2516
DELISTED
Big Lots, Inc.
BIG
| $196K | ﹤0.01% |
22,243
+5,623
| +34% | +$49.7K |
|
2517
Ginkgo Bioworks
DNA
$633M
| $194K | ﹤0.01% |
2,603
-6
| -0.2% | -$446 |
|
2518
Liquidity Services
LQDT
$849M
| $192K | ﹤0.01% |
+11,608
| New | +$192K |
|
2519
BridgeBio Pharma
BBIO
$10.1B
| $191K | ﹤0.01% |
11,125
+280
| +3% | +$4.82K |
|
2520
Genie Energy
GNE
$398M
| $190K | ﹤0.01% |
+13,454
| New | +$190K |
|
2521
Petco
WOOF
$1.02B
| $190K | ﹤0.01% |
+21,301
| New | +$190K |
|
2522
DMC Global
BOOM
$141M
| $189K | ﹤0.01% |
+10,647
| New | +$189K |
|
2523
Castle Biosciences
CSTL
$679M
| $184K | ﹤0.01% |
+13,430
| New | +$184K |
|
2524
Equinox Gold
EQX
$8.29B
| $183K | ﹤0.01% |
39,980
-696,415
| -95% | -$3.19M |
|
2525
Terns Pharmaceuticals
TERN
$641M
| $182K | ﹤0.01% |
+20,854
| New | +$182K |
|